Home 
Health FDA says J&J halted Doribax trial due to safety issues
(Reuters)
Health FDA says J&J halted Doribax trial due to safety issues
(Reuters)
| FDA says J&J halted Doribax trial due to safety issues (Reuters) |
| Thursday, 05 January 2012 | |
| Reuters - Johnson & Johnson shut down a clinical trial of its antibiotic Doribax for patients with a type of pneumonia after the drug had higher rates of death and a lower cure rate than an alternative medicine, U.S. health regulators said on Thursday. |